An open-label study changing generic clozapine formulation to FazaClo® (clozapine, USP) orally disintegrating tablets in stable patients with schizophrenia or schizoaffective disorder

被引：0

作者：

Lindenmayer, Jean-Pierre ^{[1
,2
,3
]}

Kaushik, Sashank ^{[2
,3
]}

Khan, Anzalee ^{[2
,3
]}

Kaushik, Saurabh ^{[2
,3
]}

机构：

[1] NYU, Sch Med, New York, NY USA

[2] Nathan S Kline Inst Psychiat Res, Psychopharmacol Res Program, Orangeburg, NY 10962 USA

[3] Manhattan Psychiat Ctr, Psychopharmacol Res, Wards Isl, NY USA

来源：

BIOLOGICAL PSYCHIATRY | 2008年 / 63卷 / 07期

关键词：

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

906

引用

页码：287S / 287S

页数：1

共 50 条

[1] Acceptability and Disintegration Rates of Orally Disintegrating Risperidone Tablets in Patients With Schizophrenia or Schizoaffective Disorder
Chue, Pierre
Welch, Ron
Binder, Carin
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2004, 49 (10): : 701 - 703
[2] Open-label study of mirtazapine orally disintegrating depressed tablets in depressed patients in the nursing home
Roose, SP
Nelson, JC
Salzman, C
Hollander, SB
Rodrigues, H
CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (08) : 737 - 746
[3] Bioequivalence of clozapine orally disintegrating 100-mg tablets compared with clozapine solid oral 100-mg tablets after multiple doses in patients with schizophrenia
Golden, Gil
Honigfeld, Gilbert
CLINICAL DRUG INVESTIGATION, 2008, 28 (04) : 231 - 239
[4] Bioequivalence of Clozapine Orally Disintegrating 100-mg Tablets Compared with Clozapine Solid Oral 100-mg Tablets after Multiple Doses in Patients with Schizophrenia
Gil Golden
Gilbert Honigfeld
Clinical Drug Investigation, 2008, 28 : 231 - 239
[5] Multicenter, open-label, naturalistic study of mirtazapine orally disintegrating tablets in depressed nursing home patients
Roose, SP
Nelson, JC
Salzman, C
Hollander, SB
Betzel, JV
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1079 - 1079
[6] Safety and maintenance of effect of orally disintegrating risperidone tablets in patients with major depressive disorder, bipolar disorder or dementia, results of an open-label study
Chue, P
Prinzo, R
Binder, C
BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 22S - 23S
[7] Safety and maintenance of effect of orally disintegrating risperidone tablets in patients with major depressive disorder, bipolar disorder or dementia, results of an open-label study
Chue, P.
Prinzo, R.
Binder, C.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S179 - S179
[8] Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol
de Oliveira, Irismar Reis
Elkis, Helio
Gattaz, Wagner Farid
Chaves, Ana Cristina
de Sena, Eduardo Ponde
de Matos e Souza, Fabio Gomes
Campos, Joao Alberto
Bueno, Joao Romildo
Costa e Silva, Jorge Alberto
Louza, Mario Rodrigues
de Abreu, Paulo Belmonte
CNS SPECTRUMS, 2009, 14 (02) : 93 - 102
[9] Effect of Food on the Pharmacokinetics of Clozapine Orally Disintegrating Tablet 12.5 mgA Randomized,Open-Label,Crossover Study in Healthy Male Subjects
Anthony R. DiSanto
Gil Golden
Clinical Drug Investigation, 2009, 29 : 539 - 549
[10] Effect of Food on the Pharmacokinetics of Clozapine Orally Disintegrating Tablet 12.5 mg A Randomized, Open-Label, Crossover Study in Healthy Male Subjects
DiSanto, Anthony R.
Golden, Gil
CLINICAL DRUG INVESTIGATION, 2009, 29 (08) : 539 - 549

← 1 2 3 4 5 →